These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34971496)

  • 21. A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona.
    Gaviria AM; Franco JG; Aguado V; Rico G; Labad J; de Pablo J; Vilella E
    PLoS One; 2015; 10(10):e0139403. PubMed ID: 26427051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
    Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R
    Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipsychotic medication adherence and satisfaction among Palestinian people with schizophrenia.
    Sweileh WM; Ihbesheh MS; Jarar IS; Sawalha AF; Abu Taha AS; Zyoud SH; Morisky DE
    Curr Clin Pharmacol; 2012 Feb; 7(1):49-55. PubMed ID: 22299769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship of psychological reactance, health locus of control and sense of self-efficacy with adherence to treatment in psychiatric outpatients with depression.
    De Las Cuevas C; Peñate W; Sanz EJ
    BMC Psychiatry; 2014 Nov; 14():324. PubMed ID: 25412702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients' Knowledge about Prescribed Antipsychotics and Medication Adherence in Schizophrenia: A Cross-Sectional Survey.
    Nagai N; Tani H; Suzuki T; Ikai S; Gerretsen P; Mimura M; Uchida H
    Pharmacopsychiatry; 2017 Nov; 50(6):264-269. PubMed ID: 28675911
    [No Abstract]   [Full Text] [Related]  

  • 26. Adherence to Oral Antipsychotics Measured by Electronic Adherence Monitoring in Schizophrenia: A Systematic Review and Meta-analysis.
    Yaegashi H; Kirino S; Remington G; Misawa F; Takeuchi H
    CNS Drugs; 2020 Jun; 34(6):579-598. PubMed ID: 32219681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adherence to clozapine vs. other antipsychotics in schizophrenia.
    Takeuchi H; Borlido C; Sanches M; Teo C; Harber L; Agid O; Remington G
    Acta Psychiatr Scand; 2020 Aug; 142(2):87-95. PubMed ID: 32627168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.
    Yalcin-Siedentopf N; Wartelsteiner F; Kaufmann A; Biedermann F; Edlinger M; Kemmler G; Rettenbacher MA; Widschwendter CG; Zernig G; Fleischhacker WW; Hofer A
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perceived Health Control: A Promising Step Forward in Our Understanding of Treatment Adherence in Psychiatric Care.
    De Las Cuevas C; Peñate W; Cabrera C
    J Clin Psychiatry; 2016 Oct; 77(10):e1233-e1239. PubMed ID: 27529827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should full adherence be a necessary goal in schizophrenia? Full versus non-full adherence to antipsychotic treatment.
    Acosta FJ; Ramallo-Fariña Y; Siris SG
    Compr Psychiatry; 2014 Jan; 55(1):33-9. PubMed ID: 24183886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotic Adherence, Resource Use, and Costs Before and After the Initiation of Once-monthly Paliperidone Palmitate Therapy Among Medicaid Beneficiaries With Prior Schizophrenia Relapse.
    Zhdanava M; Lin D; Lafeuille MH; Ghelerter I; Morrison L; Lefebvre P; Joshi K
    Clin Ther; 2021 Mar; 43(3):535-548. PubMed ID: 33589216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of antipsychotic polypharmacy on side-effects and concurrent use of medications in schizophrenic outpatients.
    Hashimoto Y; Uno J; Miwa T; Kurihara M; Tanifuji H; Tensho M
    Psychiatry Clin Neurosci; 2012 Aug; 66(5):405-10. PubMed ID: 22834658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Descriptions and Correlates of Medication Adherence, Attitudes, and Self-Efficacy in Outpatients With Schizophrenia Spectrum Disorders (SSDs).
    Beebe LH; Smith K; Phillips C
    Arch Psychiatr Nurs; 2016 Jun; 30(3):400-5. PubMed ID: 27256948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attitudes toward antipsychotic medication, insight and psychopathology in outpatients with schizophrenia.
    Vassileva IV; Milanova VK
    Folia Med (Plovdiv); 2012; 54(4):62-8. PubMed ID: 23441471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Daily functioning and symptom factors contributing to attitudes toward antipsychotic treatment and treatment adherence in outpatients with schizophrenia spectrum disorders.
    Leijala J; Kampman O; Suvisaari J; Eskelinen S
    BMC Psychiatry; 2021 Jan; 21(1):37. PubMed ID: 33441112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should antipsychotic medications for schizophrenia be given for a lifetime? Replication of a naturalistic, long-term, follow-up study of antipsychotic treatment.
    Glick ID; Zamora D; Kamis D; Davis JM
    CNS Spectr; 2019 Oct; 24(5):557-563. PubMed ID: 30777584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PREVALENCE AND PREDICTORS OF MEDICATION ADHERENCE AMONG PATIENTS WITH SCHIZOPHRENIA IN MAIDUGURI, NORTHEASTERN NIGERIA.
    Shettima F; Sheikh T; Wakil M; Wakama I; Abdulaziz M; Rabbebe I
    West Afr J Med; 2023 Nov; 40(11 Suppl 1):S21-S22. PubMed ID: 37976234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison.
    Roh D; Chang JG; Kim CH; Cho HS; An SK; Jung YC
    Aust N Z J Psychiatry; 2014 Jan; 48(1):52-60. PubMed ID: 23671214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.